A detailed history of Seven Bridge Financial Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Seven Bridge Financial Group, LLC holds 20,892 shares of ABBV stock, worth $3.76 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares
20,892
Previous 20,529 1.77%
Holding current value
$3.76 Million
Previous $3.52 Million 17.15%
% of portfolio
0.75%
Previous 0.76%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$163.84 - $199.33 $59,473 - $72,356
363 Added 1.77%
20,892 $4.13 Million
Q2 2024

Aug 09, 2024

BUY
$154.79 - $180.76 $41,483 - $48,443
268 Added 1.32%
20,529 $3.52 Million
Q1 2024

May 10, 2024

SELL
$159.82 - $182.1 $25,571 - $29,136
-160 Reduced 0.78%
20,261 $3.69 Million
Q4 2023

Jan 22, 2024

SELL
$137.6 - $154.97 $12,108 - $13,637
-88 Reduced 0.43%
20,421 $3.16 Million
Q3 2023

Oct 25, 2023

BUY
$133.59 - $154.65 $55,439 - $64,179
415 Added 2.07%
20,509 $3.06 Million
Q2 2023

Jul 26, 2023

BUY
$132.51 - $164.9 $16,696 - $20,777
126 Added 0.63%
20,094 $2.71 Million
Q1 2023

Apr 20, 2023

BUY
$144.61 - $166.54 $56,397 - $64,950
390 Added 1.99%
19,968 $3.18 Million
Q4 2022

Jan 26, 2023

BUY
$138.31 - $165.87 $21,438 - $25,709
155 Added 0.8%
19,578 $0
Q3 2022

Oct 17, 2022

BUY
$134.21 - $153.93 $1.06 Million - $1.22 Million
7,915 Added 68.78%
19,423 $2.61 Million
Q2 2022

Jul 12, 2022

SELL
$137.62 - $174.96 $1,789 - $2,274
-13 Reduced 0.11%
11,508 $1.76 Million
Q1 2022

Apr 15, 2022

SELL
$131.98 - $163.75 $217,107 - $269,368
-1,645 Reduced 12.49%
11,521 $1.87 Million
Q4 2021

Jan 20, 2022

BUY
$107.43 - $135.93 $1.41 Million - $1.79 Million
13,166 New
13,166 $1.78 Million
Q4 2021

Jan 20, 2022

SELL
$107.43 - $135.93 $1.21 Million - $1.54 Million
-11,298 Closed
0 $0
Q3 2021

Oct 14, 2021

SELL
$106.4 - $120.78 $32,239 - $36,596
-303 Reduced 2.61%
11,298 $1.22 Million
Q2 2021

Jul 26, 2021

BUY
$105.21 - $117.21 $77,013 - $85,797
732 Added 6.73%
11,601 $1.31 Million
Q1 2021

Apr 20, 2021

BUY
$102.3 - $112.62 $49,513 - $54,508
484 Added 4.66%
10,869 $1.18 Million
Q4 2020

Jan 19, 2021

BUY
$80.49 - $108.67 $147,699 - $199,409
1,835 Added 21.46%
10,385 $1.11 Million
Q3 2020

Oct 22, 2020

BUY
$85.91 - $100.83 $12,199 - $14,317
142 Added 1.69%
8,550 $749,000
Q2 2020

Jul 24, 2020

SELL
$73.37 - $98.18 $20,543 - $27,490
-280 Reduced 3.22%
8,408 $825,000
Q1 2020

Apr 16, 2020

BUY
$64.5 - $97.79 $57,469 - $87,130
891 Added 11.43%
8,688 $662,000
Q4 2019

Jan 17, 2020

BUY
$72.13 - $90.25 $44,504 - $55,684
617 Added 8.59%
7,797 $690,000
Q3 2019

Oct 09, 2019

SELL
$62.98 - $75.72 $32,560 - $39,147
-517 Reduced 6.72%
7,180 $544,000
Q2 2019

Jul 15, 2019

BUY
$65.7 - $83.98 $30,222 - $38,630
460 Added 6.36%
7,697 $560,000
Q1 2019

May 14, 2019

SELL
$77.14 - $90.79 $10,105 - $11,893
-131 Reduced 1.78%
7,237 $583,000
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $1.3 Million - $1.6 Million
-16,706 Reduced 69.39%
7,368 $679,000
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $16,803 - $18,680
-189 Reduced 0.78%
24,074 $2.28 Million
Q2 2018

Aug 14, 2018

BUY
$89.78 - $106.23 $44,530 - $52,690
496 Added 2.09%
24,263 $2.25 Million
Q1 2018

May 11, 2018

BUY
$92.01 - $123.21 $5,520 - $7,392
60 Added 0.25%
23,767 $2.25 Million
Q4 2017

Feb 20, 2018

SELL
$89.56 - $98.21 $44,869 - $49,203
-501 Reduced 2.07%
23,707 $2.29 Million
Q3 2017

Nov 13, 2017

BUY
$69.85 - $89.22 $57,207 - $73,071
819 Added 3.5%
24,208 $2.15 Million
Q2 2017

Aug 14, 2017

BUY
N/A
23,389
23,389 $1.7 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Seven Bridge Financial Group, LLC Portfolio

Follow Seven Bridge Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Bridge Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Seven Bridge Financial Group, LLC with notifications on news.